Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association;Analyse rétrospective de 108 carcinomes canalaires in situ mammaires traités par association radiochirurgicale

Cancer/Radiotherapie

Volumn 10, Issue 8, 2006, Pages 550-558

  Fourneret, P ^a   Artignan, X ^a   De Cornulier, J ^a   Pasquier, D ^a   Panh, M H ^e   Payan, R ^b   Kolodie H ^a   Vincent, F ^a   Fric, D ^c   Bernard, P ^a   Colona, M ^a,d   Bolla, M ^a,d  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Clinique Belledone   (France)

^c Clinique du Mail   (France)

^d Off Departemental Lutte Contre L   (France)

^e Registre du cancer de l'Isère ^*  (France)

Author keywords

Breast; Conservative surgery; Ductal carcinomas in situ; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; DISSECTION; EXCISION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MAMMARY GLAND; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIOSURGERY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33845287963     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.06.010     Document Type: Article

References (52)

1. Arnesson L.G., Smeds S., Fagerberg G., and Gröntoft O. Follow-up of two treatment modalities for ductal cancer in situ of the breast. Br. J. Surg. 76 (1989) 672-675
2. Ashikari R., Huvos A.G., and Snyder R.E. Prospective study of non-infiltrating carcinoma of the breast. Cancer 39 (1977) 435-439
3. Baird R.M., Worth A., and Hislop G. Recurrence after lumpectomy for comedotype intraductal carcinoma of the breast. Am. J. Surg. 159 (1990) 479-481
4. Barillot I., Cutuli B., and Arnould L. Carcinome canalaire in situ : est-il vraiment éthique de considérer le traitement conservateur comme un standard ?. Cancer Radiother. 8 (2004) 9-20
5. Bellamy C.O., McDonald C., Salter D.M., Chetty U., and Anderson T.J. Non-invasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum. Pathol. 24 (1993) 16-23
6. Bijker N., Peterse J.L., Duchateau L., Julien J.P., Fentiman I.S., Duval C., et al. Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: Analysis of European Organization for Research and treatment of cancer Trial 10853. J. Clin. Oncol. 19 (2001) 2263-2271
7. Bornstein B.A., Recht A., Connolly J.L., Schnitt S.J., Cady B., Koufman C., et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 67 (1991) 7-13
8. Boyages J., Delaney G., and Taylor R. Predictors of local recurrence after treatment ductal carcinoma in situ. A meta-analysis. Cancer 85 (1999) 616-628
9. Carpenter R., Boulter P.S., Cooke T., and Gibbs N.M. Management of screen detected ductal carcinoma in situ of the female breast. Br. J. Surg. 76 (1989) 564-567
10. Chan K.C., Knox W.F., Sinha G., Gandhi A., Barr L., Baildam A.D., et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 91 (2001) 9-16
11. Cutuli B., Cohen-Solal-Le Nir C., De Lafontan B., Mignotte H., Fichet V., Fay R., et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Center's experience. Int. J. Radiat. Oncol. Phys. 53 (2002) 868-879
12. Cutuli B., Cohen-Solal-Le Nir B., De Lafontan H., Mignotte H., Fichet V., Fay R., et al. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur. J. Cancer 37 (2001) 2365-2372
13. Cutuli B., Teissier E., Piat J.M., Janser J.C., Renaud R., Rodier J.F., et al. Radical surgery and conservative treatment of ductal carcinoma in situ of the breast. Eur. J. Cancer 28 (1992) 649-654
14. de Lafontan B., Daures J.P., Salicru B., Eynuis F., Milhura J., Rouanet P., et al. Isolated clustered microcalcifications diagnostic value of mammography. Series of 400 cases with surgical verification. Radiology 190 (1994) 479-483
15. De la Rochefordiere A., Asselain B., Campana F., et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 341 (1993) 1039-1043
16. Denoux Y., Marnay J., Crouet R., Boute M., Delozier T., Vie B., et al. Évaluation des facteurs prédictifs des récidives locales, en particulier l'index de Van Nuys, dans les carcinomes intracanalaires du sein : étude de 166 cas avec traitement conservateur et revue de la littérature. Bull. Cancer. 88 (2001) 419-425
17. Exbrayat C., Garnier A., Bolla M., Winckel P., Salicru B., Marron J., et al. Dépistage simultané des cancers du sein, du col, du côlon-rectum. Expérience de l'Isère. Bull. Cancer 83 (1996) 641-648
18. Exbrayat C., Garnier A., Mignee M.J., Beck P., Evrad, Menegoz F., et al. Campagne de dépistage des cancers. Département de l'Isère. Rapport final d'évaluation pour la CNAMTS (1995)
19. Fisher B., Costantino J., Redmond C., Fisher E., Margolese R., Dimitrov N., et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N. Engl. J. Med. 328 (1993) 1581-1586
20. Fisher B., Digman J., Wolmark N., Mamounas E., Costantino J., Poller J., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J. Clin. Oncol. 16 (1998) 441-452
21. Fisher B., Digman J., Wolmark N., Wickerham D.L., Fisher E.R., Mamounas R.S., et al. Tamoxifen in treatment of intraductal breast cancer: National surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet 353 (1999) 1993-1999
22. Fisher E.R., Costantino J., Fisher B., Palekar A.S., Redmond C., and Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Cancer 75 (1995) 1310-1319
23. Fourquet A., Zafrani B., Campana F., Durand J.C., and Vilcoq J.R. Breast-conserving treatment of ductal carcinoma in situ. Semin. Radiat. Oncol. 2 (1992) 116-124
24. Fowble B., Hanlon A.L., Fein D.A., Hoffman J.P., Sigurdson E.R., Patchefsky A., et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int. J. Radiat. Oncol. Biol. Phys. 38 (1997) 949-957
25. Gallagher W.J., Koerner F.C., and Wood W.C. Treatment of intraductal carcinoma with limited surgery: long-term follow-up. J. Clin. Oncol. 7 (1989) 376-380
26. Grenier B. Évaluation de la décision médicale : introduction à l'analyse médicoéconomique (1996), Masson, Paris (collection : évaluation et statistique)
27. Hill C., Com-Nougé C., Kramar A., Moreau T., O'Quigley J., Senoussi R., et al. Analyse statistique des données de survie (1990), Inserm, Paris
28. Holland P.A., Gandhi A., Knox W.F., et al. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ of the breast. Br. J. Cancer 77 (1998) 110-114
29. Holland R., Hendriks J.H.C.L., Verbeek A.L.M., Mravunac M., and Schuurmans Stekhoven J.H. Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335 (1990) 519-522
30. Holland R., Peterse J.L., Millis R.R., Eusebi V., Faverly D., van de Vijver M.J., et al. Ductal carcinoma in situ: a proposal for a new classification. Semin. Diagn. Pathol. 11 (1994) 167-180
31. Julien J.P., Bijker N., Fentiman I.S., Peterse J.L., Delledonne V., Rouanet P., et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 355 (2000) 528-533
32. Kuske R.R., Bean J.M., Garcia D.M., Perez C.A., Andriole D., Philipott G., et al. Breast conservation therapy for intraductal carcinoma of the breast. Int. J. Radiat. Oncol. Phys. 26 (1993) 391-396
33. Lagios M.D. Duct carcinoma in situ. Pathology and treatment. Surg. Clin. N. Am. 70 (1990) 853-871
34. Lagios M.D., Margolin F.R., Westdahl P.R., and Rose M.R. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63 (1989) 618-624
35. Lagios M.D., Westdahl P.R., Margolin F.R., and Rose M.R. Duct carcinoma in situ relationship of extent of non-invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50 (1982) 1309-1314
36. Ottesen G.L., Graversen H.P., Blichert-Toft M., Zedeler K., and Andersen J.A. Ductal carcinoma in situ of the female breast: short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am. J. Surg. Pathol. 16 (1992) 1183-1196
37. Page D.L., and Anderson T.J. Diagnostic histopathology of the breast (1987), Churchill Livingstone, Edinburgh
38. Ray G.R., Adelson J., Hayhurst E., et al. Ductal carcinoma in situ of the breast: results of treatment by conservative surgery and definitive irradiation. Int. J. Radiat. Oncol. Phys. 28 (1994) 105-111
39. Ringberg A., Idvall I., Anagnostaki L., et al. Morphological and clinical characteristics in patients with ipsilaterals recurrence after DCIS. Eur. J. Cancer 30A (1994) 574 (abstract)
40. Rosen P.P., and Oberman H.A. Intraepithelial (pre-invasive or in situ) carcinoma. Tumors of the mammary gland (1993), Armed Forces Institute of Pathology, Washington 119-155 (collection: Atlas of Tumor Pathology, vol 7)
41. Schwartz G.F., Finkel G.C., Garcia J.C., and Patchefsky A.S. Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer 70 (1992) 2468-2474
42. Schwartz G.F., Solin J.L., Olivotto I.A., Ernster V.L., and Pressman P.I. Consensus Conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer 88 (2000) 946-954
43. Silverstein M.J., Barth A., Poller D.N., Gierson E.D., Colburn W.J., Waisman J.R., et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur. J. Cancer 31A (1995) 1425-1427
44. Silverstein M.J., Cohlan B.F., Gierson E.D., Furmanski M., Gamagami P., Colburn W.J., et al. Duct carcinoma in situ: 227 cases without micro-invasion. Eur. J. Cancer 28 (1992) 630-634
45. Silverstein M.J., Lagios M.D., Craig P.H., Waisman J.R., Lewinsky B.S., Colburn W.J., et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 77 (1996) 2267-2274
46. Silverstein M.J., Lagios M.D., Graig P.H., Groshen S., Waisman J.R., Lewinsky B.S., et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N. Engl. J. Med. 340 19 (1999) 1455-1461
47. Solin L.J., Fourquet A., Vicini F.A., Haffty B., Taylor M., McCormick B., et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int. J. Radiat. Oncol. Phys. 50 (2001) 991-1002
48. Sunshine J.A., Moseley H.S., Fletcher W.S., Krippaehne W.W., et al. Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10-year follow-up. Am. J. Surg. 150 (1985) 44-51
49. Van Zee K.J., Liberman L., Samli B., Tran K.N., McCormick B., Petrek J.A., et al. Long-term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer 86 (1999) 1757-1767
50. Veronesi U., Banfi A., and Delvecchio M. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection and radiotherapy in early breast cancer. Long term results. Int. J. Cancer Chir. Oncol. 22 (1986) 1085-1089
51. Vicini F.A., Kestin L.L., Goldstein N.S., Baglan K.L., Pettinga J.E., and Martinez A.A. Relationship between excision volume, margin status, and tumour size with the development of local recurrence in patients with ductal carcinoma in situ breast- conserving therapy. J. Surg. Oncol. 76 (2001) 245-254
52. Vogel V.G., Constantino J.P., Wickerham D.L., and Cronin W.M. National Surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ. Clin. Cancer Res. 9 (2003) 4955-5015